Skip to main content
. 2008 Oct 30;23(5):825–832. doi: 10.3346/jkms.2008.23.5.825

Fig. 3.

Fig. 3

Cell cycle progression of 5637 cells following different treatments as indicated. (A) Flow cytometry graphs. (B) Quantification of the percentages of cells in G0/G1 phase and S phase.

*Statistically significant (p<0.05, mean±SD, n=10) relative to control shRNA.